These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

344 related items for PubMed ID: 29938562

  • 1. Plasma and serum brain-derived neurotrophic factor (BDNF) levels and their association with neurocognition in at-risk mental state, first episode psychosis and chronic schizophrenia patients.
    Heitz U, Papmeyer M, Studerus E, Egloff L, Ittig S, Andreou C, Vogel T, Borgwardt S, Graf M, Eckert A, Riecher-Rössler A.
    World J Biol Psychiatry; 2019 Sep; 20(7):545-554. PubMed ID: 29938562
    [Abstract] [Full Text] [Related]

  • 2. Plasma brain-derived neurotrophic factor levels, learning capacity and cognition in patients with first episode psychosis.
    Ruiz de Azua S, Matute C, Stertz L, Mosquera F, Palomino A, de la Rosa I, Barbeito S, Vega P, Kapczinski F, González-Pinto A.
    BMC Psychiatry; 2013 Jan 15; 13():27. PubMed ID: 23320462
    [Abstract] [Full Text] [Related]

  • 3. Correlates of neurocognitive functions in individuals at ultra-high risk for psychosis - A 6-month follow-up study.
    Sanada K, de Azúa SR, Nakajima S, Alberich S, Ugarte A, Zugasti J, Vega P, Martínez-Cengotitabengoa M, González-Pinto A.
    Psychiatry Res; 2018 Oct 15; 268():1-7. PubMed ID: 29986171
    [Abstract] [Full Text] [Related]

  • 4. Brain derived Neurotropic Factor (BDNF) is associated with childhood abuse but not cognitive domains in first episode psychosis.
    Theleritis C, Fisher HL, Shäfer I, Winters L, Stahl D, Morgan C, Dazzan P, Breedvelt J, Sambath I, Vitoratou S, Russo M, Reichenberg A, Falcone MA, Mondelli V, O'Connor J, David A, McGuire P, Pariante C, Di Forti M, Murray RM, Bonaccorso S.
    Schizophr Res; 2014 Oct 15; 159(1):56-61. PubMed ID: 25171858
    [Abstract] [Full Text] [Related]

  • 5. Lower Brain-Derived Neurotropic Factor Levels in Untreated Adolescents With First-Episode Psychosis.
    Şimşek Ş, Gençoğlan S, Yüksel T, Kaplan İ, Aktaş H.
    J Clin Psychopharmacol; 2015 Oct 15; 35(5):596-9. PubMed ID: 26267416
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Associations of serum brain-derived neurotrophic factor with cognitive impairments and negative symptoms in schizophrenia.
    Niitsu T, Shirayama Y, Matsuzawa D, Hasegawa T, Kanahara N, Hashimoto T, Shiraishi T, Shiina A, Fukami G, Fujisaki M, Watanabe H, Nakazato M, Asano M, Kimura S, Hashimoto K, Iyo M.
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Dec 01; 35(8):1836-40. PubMed ID: 21930178
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Cognitive impairments and low BDNF serum levels in first-episode drug-naive patients with schizophrenia.
    Man L, Lv X, Du XD, Yin G, Zhu X, Zhang Y, Soares JC, Yang XN, Chen X, Zhang XY.
    Psychiatry Res; 2018 May 01; 263():1-6. PubMed ID: 29482040
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Gender difference in association of cognition with BDNF in chronic schizophrenia.
    Zhang XY, Chen DC, Tan YL, Tan SP, Wang ZR, Yang FD, Xiu MH, Hui L, Lv MH, Zunta-Soares GB, Soares JC.
    Psychoneuroendocrinology; 2014 Oct 01; 48():136-46. PubMed ID: 24999831
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Deterioration of visuospatial associative memory following a first psychotic episode: a long-term follow-up study.
    Wannan CMJ, Bartholomeusz CF, Cropley VL, Van Rheenen TE, Panayiotou A, Brewer WJ, Proffitt TM, Henry L, Harris MG, Velakoulis D, McGorry P, Pantelis C, Wood SJ.
    Psychol Med; 2018 Jan 01; 48(1):132-141. PubMed ID: 28625185
    [Abstract] [Full Text] [Related]

  • 18. Relationships between serum brain-derived neurotrophic factor, plasma catecholamine metabolites, cytokines, cognitive function and clinical symptoms in Japanese patients with chronic schizophrenia treated with atypical antipsychotic monotherapy.
    Hori H, Yoshimura R, Katsuki A, Atake K, Igata R, Konishi Y, Nakamura J.
    World J Biol Psychiatry; 2017 Aug 01; 18(5):401-408. PubMed ID: 27409727
    [Abstract] [Full Text] [Related]

  • 19. Decreased BDNF in patients with antipsychotic naïve first episode schizophrenia.
    Jindal RD, Pillai AK, Mahadik SP, Eklund K, Montrose DM, Keshavan MS.
    Schizophr Res; 2010 Jun 01; 119(1-3):47-51. PubMed ID: 20096541
    [Abstract] [Full Text] [Related]

  • 20. Longitudinal assessment of brain-derived neurotrophic factor in Sardinian psychotic patients (LABSP): a protocol for a prospective observational study.
    Primavera D, Manchia M, Deriu L, Tusconi M, Collu R, Scherma M, Fadda P, Fratta W, Carpiniello B.
    BMJ Open; 2017 May 25; 7(5):e014938. PubMed ID: 28550022
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.